Kiyoshi Kurokawa

Author PubWeight™ 94.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2003 3.90
2 Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2005 3.56
3 Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003 3.53
4 Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int 2003 2.65
5 Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS). Am J Kidney Dis 2007 2.03
6 Health-related quality of life among dialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2003 1.86
7 Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2007 1.85
8 Mortality among hemodialysis patients in Europe, Japan, and the United States: case-mix effects. Am J Kidney Dis 2004 1.84
9 Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin. Kidney Int 2010 1.67
10 Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering. J Am Soc Nephrol 2005 1.64
11 Glutamate receptor antagonists and benzodiazepine inhibit the progression of granule cell dispersion in a mouse model of mesial temporal lobe epilepsy. Epilepsia 2005 1.53
12 Evidence of tubular hypoxia in the early phase in the remnant kidney model. J Am Soc Nephrol 2004 1.52
13 Improving outcomes for dialysis patients in the international Dialysis Outcomes and Practice Patterns Study. Clin J Am Soc Nephrol 2006 1.47
14 Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int 2004 1.42
15 Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 2003 1.40
16 Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney Int 2004 1.36
17 Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients. Nephrol Dial Transplant 2003 1.29
18 Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan dialysis outcomes and practice patterns study. Hemodial Int 2007 1.26
19 Inhibition of plasminogen activator inhibitor-1: its mechanism and effectiveness on coagulation and fibrosis. Arterioscler Thromb Vasc Biol 2008 1.26
20 Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial. Am J Kidney Dis 2009 1.23
21 Kidney transplantation and wait-listing rates from the international Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2005 1.20
22 Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study. Diabetes Care 2004 1.15
23 Involvement of endoplasmic reticulum (ER) stress in podocyte injury induced by excessive protein accumulation. Kidney Int 2005 1.14
24 Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2003 1.14
25 Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms. J Am Soc Nephrol 2002 1.13
26 Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model. J Am Soc Nephrol 2003 1.08
27 Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5D. Am J Nephrol 2011 1.03
28 Efficient in vitro lowering of carbonyl stress by the glyoxalase system in conventional glucose peritoneal dialysis fluid. Kidney Int 2002 1.02
29 Overexpression of the serpin megsin induces progressive mesangial cell proliferation and expansion. J Clin Invest 2002 1.01
30 Differential expression of nuclear lamin, the major component of nuclear lamina, during neurogenesis in two germinal regions of adult rat brain. Eur J Neurosci 2007 1.00
31 Hypoxia-induced apoptosis in cultured glomerular endothelial cells: involvement of mitochondrial pathways. Kidney Int 2003 1.00
32 Calcium homeostasis and imbalance. Nephron 2002 0.97
33 A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin overexpression in RAGE/iNOS transgenic mice. Diabetes 2006 0.96
34 Prescription patterns and mineral metabolism abnormalities in the cinacalcet era: results from the MBD-5D study. Clin J Am Soc Nephrol 2012 0.96
35 In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy. Nephrol Dial Transplant 2005 0.96
36 Re-invigorating Japan's commitment to global health: challenges and opportunities. Lancet 2011 0.96
37 Mineral and bone disorders outcomes study for Japanese chronic kidney disease stage 5D patients: rationale and study design. Ther Apher Dial 2011 0.93
38 nanos1: a mouse nanos gene expressed in the central nervous system is dispensable for normal development. Mech Dev 2003 0.93
39 C-reactive protein and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephron Clin Pract 2010 0.92
40 Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone. Nephrol Dial Transplant 2005 0.92
41 The organization and financing of end-stage renal disease treatment in Japan. Int J Health Care Finance Econ 2007 0.91
42 Novel serpinopathy in rat kidney and pancreas induced by overexpression of megsin. J Am Soc Nephrol 2005 0.90
43 Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure. Am J Kidney Dis 2002 0.90
44 Japanese haemodialysis anaemia management practices and outcomes (1999-2006): results from the DOPPS. Nephrol Dial Transplant 2008 0.89
45 Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats. Kidney Int 2003 0.89
46 Decreases in PTH in Japanese hemodialysis patients with secondary hyperparathyroidism: associations with changing practice patterns. Clin J Am Soc Nephrol 2011 0.86
47 Estimating a preference-based index from the Japanese SF-36. J Clin Epidemiol 2009 0.86
48 [Guidelines for the management of rapidly progressive glomerulonephritis]. Nihon Jinzo Gakkai Shi 2002 0.86
49 Long-term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by colour Doppler ultrasonography. Nephrol Dial Transplant 2003 0.85
50 Renal osteodystrophy and secondary hyperparathyroidism. Nephrol Dial Transplant 2002 0.85
51 Impact of early referral to nephrologist on mental health among hemodialysis patients: a Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephron Clin Pract 2009 0.83
52 Glucose dialysate induces mitochondrial DNA damage in peritoneal mesothelial cells. Perit Dial Int 2002 0.83
53 Mesangial cell-predominant functional gene, megsin. Clin Exp Nephrol 2003 0.83
54 Sphingosine 1-phosphate stimulates rat mesangial cell proliferation from outside the cells. Nephrol Dial Transplant 2002 0.83
55 Clinical effect of short daily in-center hemodialysis. Nephron Clin Pract 2003 0.83
56 Depressive symptoms predict the subsequent risk of bodily pain in dialysis patients: Japan Dialysis Outcomes and Practice Patterns Study. Pain Med 2009 0.83
57 Hypercalcaemia is associated with poor mental health in haemodialysis patients: results from Japan DOPPS. Nephrol Dial Transplant 2007 0.83
58 Long-term effect of 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients. One-year administration study. Nephrol Dial Transplant 2002 0.82
59 Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study. Nephron Clin Pract 2008 0.82
60 Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes. Kidney Int 2002 0.82
61 Vascular access care and treatment practices associated with outcomes of arteriovenous fistula: international comparisons from the Dialysis Outcomes and Practice Patterns Study. Nephron Clin Pract 2013 0.82
62 Beta-blocker prescription and outcomes in hemodialysis patients from the Japan Dialysis Outcomes and Practice Patterns Study. Nephron Clin Pract 2009 0.82
63 Time-dependent resistance to erythropoiesis-stimulating agent and mortality in hemodialysis patients in the Japan Dialysis Outcomes and Practice Patterns Study. Nephron Clin Pract 2013 0.81
64 Disappearance of association in diabetic patients on hemodialysis between anemia and mortality risk: the Japan dialysis outcomes and practice pattern study. Nephron Clin Pract 2012 0.81
65 Very high doses of valsartan provide renoprotection independently of blood pressure in a type 2 diabetic nephropathy rat model. Nephrology (Carlton) 2009 0.81
66 Cost-effectiveness of administering oral adsorbent AST-120 to patients with diabetes and advance-stage chronic kidney disease. Diabetes Res Clin Pract 2010 0.81
67 Menatetrenone prevents osteoblast dysfunction in unilateral sciatic neurectomized rats. Jpn J Pharmacol 2002 0.80
68 Long-term prognosis of parathyroid function for chronic dialysis patients after minimally invasive radioguided parathyroidectomy (MIRP). Nephrol Dial Transplant 2003 0.79
69 Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure. Clin Sci (Lond) 2002 0.79
70 Combination use of vitamin K(2) further increases bone volume and ameliorates extremely low turnover bone induced by bisphosphonate therapy in tail-suspension rats. J Bone Miner Metab 2003 0.79
71 Maintenance of trabecular structure and bone volume by vitamin K(2) in mature rats with long-term tail suspension. J Bone Miner Metab 2002 0.78
72 Mesangial cell-predominant gene, megsin. Nephrol Dial Transplant 2002 0.78
73 Ultrapure dialysate decreases plasma pentosidine, a marker of "carbonyl stress". Am J Kidney Dis 2004 0.78
74 Transcriptional regulation of a mesangium-predominant gene, megsin. J Am Soc Nephrol 2002 0.78
75 Prognosis of parathyroid function after minimally invasive radioguided parathyroidectomy (MIRP) and percutaneous ethanol injection therapy (PEIT) for primary hyperparathyroidism. Biomed Pharmacother 2002 0.77
76 Abnormal iron deposition in renal cells in the rat with chronic angiotensin II administration. Lab Invest 2002 0.77
77 Establishment of a sandwich ELISA for human megsin, a kidney-specific serine protease inhibitor. Nephrol Dial Transplant 2007 0.77
78 ET(B) receptor protects the tubulointerstitium in experimental thrombotic microangiopathy. Kidney Int 2002 0.77
79 [Long-term clinical effect of maxacalcitol on hemodialysis patients with secondary hyperparathyroidism]. Clin Calcium 2002 0.77
80 Tagging of avidin immobilized beads with biotinylated YAG:Ce3+ nanocrystal phosphor. Anal Bioanal Chem 2006 0.77
81 Menatetrenone ameliorates reduction in bone mineral density and bone strength in sciatic neurectomized rats. J Nutr Sci Vitaminol (Tokyo) 2003 0.76
82 Menatetrenone rescues bone loss by improving osteoblast dysfunction in rats immobilized by sciatic neurectomy. Life Sci 2004 0.76
83 Overview of the clinical application of regenerative medicine products in Japan. Health Policy 2008 0.76
84 Differential responses of endogenous adult mouse neural precursors to excess neuronal excitation. Eur J Neurosci 2012 0.76
85 Dose-response study of 22-oxacalcitriol in patients with secondary hyperparathyroidism. Ther Apher Dial 2004 0.76
86 From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy: a detective story. Curr Drug Targets Immune Endocr Metabol Disord 2005 0.76
87 Expression of RET in follicular cell-derived tumors of the thyroid gland: prevalence and implication of morphological type. Pathol Int 2003 0.76
88 Prognostic factors for a composite end-point of renal outcomes in patients with chronic kidney disease. Ther Apher Dial 2006 0.75
89 [Guidelines for the management of refractory nephrotic syndrome--from investigations between 1997 and 2001--research project team for progressive renal lesions in the Ministry of Health, Labor and Welfare, Japan]. Nihon Jinzo Gakkai Shi 2002 0.75
90 New clinical guidelines for selective direct injection therapy of the parathyroid glands in chronic dialysis patients. NDT Plus 2008 0.75
91 A comparison between daily and thrice-weekly i.v. administration of 1,25-dihydroxy-22-oxavitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic action in uraemic rats. Nephrol Dial Transplant 2002 0.75
92 [A study about normal values of urinary type IV collagen concentration--aim at constructing a diagnostic guideline for diabetic nephropathy]. Nihon Jinzo Gakkai Shi 2002 0.75
93 [Post-genomic studies on kidney diseases and genomic drug design]. Nihon Rinsho 2006 0.75
94 [History of nephrology in the past 100 years and the future prospects]. Nihon Naika Gakkai Zasshi 2002 0.75
95 Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid. Kidney Int 2003 0.75
96 [Renal osteodystrophy and secondary hyperparathyroidism]. Clin Calcium 2002 0.75
97 [Study of dialysis outcomes and practice patterns]. Nihon Rinsho 2004 0.75
98 Proteomics and mesangial cell: serpin, megsin and plasmin. Contrib Nephrol 2004 0.75
99 [Clinical development of OCT]. Clin Calcium 2002 0.75
100 Adenovirus-mediated functional gene transfer into parathyroid cells in vivo and in vitro. Nephrol Dial Transplant 2003 0.75
101 [Tasks in medical care in Japan and the world]. Nihon Naika Gakkai Zasshi 2006 0.75
102 Accelerated glomerular injury in hemi-nephrectomized transgenic mice of mesangial cell-predominant serpin, megsin. Nephron Exp Nephrol 2004 0.75
103 Crossreaction with an anti-Bax antibody reveals novel multi-endocrine cellular antigen. J Histochem Cytochem 2004 0.75
104 A detective story for biomedical footprints towards new therapeutic interventions in diabetic nephropathy. Intern Med 2003 0.75
105 Study design and methods for a clinical trial of an oral carbonaceous adsorbent used to prevent the progression of chronic kidney disease (CAP-KD). Clin Exp Nephrol 2005 0.75
106 [Carbonyl stress inhibitor towards new therapeutic interventions in diabetic nephropathy]. Nihon Rinsho 2004 0.75
107 Recession Watch: No time for nationalism. Nature 2009 0.75
108 [Preventive effect of the oral carbonaceous absorbent for progression of chronic kidney failure: report of a RCT]. Nihon Jinzo Gakkai Shi 2008 0.75
109 Mouse Flamingo1/Celsr2 relates neuronal reorganization of the hypertrophic dentate granule cells after kainate injection. Brain Res 2003 0.75
110 Opening Japan up to the world. Science 2008 0.75
111 The unique role of nephrologists in the pursuit of global health goals. Nat Clin Pract Nephrol 2008 0.75